Yearly Archives: 2024

Community Pharmacy England CEO Janet Morrison has given a video update on the Community Pharmacy Contractual Framework (CPCF) negotiations, addressing the prolonged pause that means the sector is still without an agreement for 2024/25. In her video message, Janet addresses the continued delay in recommencing negotiations, describing the “severe frustration and intense anger” that the [...]

The post CPCF Negotiations Update: A message from our CEO appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) Drug alert number: EL (24)A/61 Date issued: 4 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) DMRC reference number:DMRC-34033472 Company [...]

The post MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) appeared first on Community Pharmacy England.

Community Pharmacy England has made a submission to the Government’s development of a 10-year Health Plan for the NHS, highlighting the benefits of increased commissioning of pharmacy services in tandem with addressing the sector’s current funding gap. In October, the Secretary of State for Health and Social Care launched a national conversation on the NHS, seeking [...]

The post Community Pharmacy England submits proposals for NHS 10-Year Plan appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (03/12/2024) announced the following final list of price concessions for November 2024: Please note these prices only apply to prescriptions submitted as dispensed in November 2024. Community Pharmacy [...]

The post November 2024 Price Concessions Final Update appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) Drug alert number: EL (24)A/60 Date issued: 3 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) DMRC reference number: DMRC-31179592 Company name: [...]

The post MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) appeared first on Community Pharmacy England.